We are live on ! Find out more
PDSB icon

PDS Biotechnology
PDSB

48 hedge funds and large institutions have $9.81M invested in PDS Biotechnology in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

15,650% more call options, than puts

Call options by funds: $315K | Put options by funds: $2K

41% more capital invested

Capital invested by funds: $6.94M → $9.81M (+$2.87M)

6.78% more ownership

Funds ownership: 11.37% → 18.15% (+6.8%)

8% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 12

8% less funds holding

Funds holding: 52 → 48 (-4)

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

Holders
48
Holders Change
-4
Holders Change %
-7.69%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
11
Reduced
12
Closed
12
Calls
$315K
Puts
$2K
Net Calls
+$313K
Net Calls Change
+$169K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$6.29M
2
UBS Group
UBS Group
Switzerland
+$286K
3
William Blair & Company
William Blair & Company
Illinois
+$142K
4
IGGA
Iron Gate Global Advisors
Utah
+$107K
5
VPIM
Vanguard Personalized Indexing Management
California
+$40.6K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$315K
2
Citadel Advisors
Citadel Advisors
Florida
-$313K
3
Renaissance Technologies
Renaissance Technologies
New York
-$163K
4
Millennium Management
Millennium Management
New York
-$108K
5
Two Sigma Investments
Two Sigma Investments
New York
-$107K
Name Holding Trade Value Shares
Change 		Change in
Stake
Raymond James Financial
26
Raymond James Financial
Florida
$16.6K -$2.7K -1,900 -12%
SFP
27
Sandbox Financial Partners
Maryland
$15.1K +$18K +12,666 New
Mercer Global Advisors
28
Mercer Global Advisors
Colorado
$14.9K – – –
JWBC
29
J.W. Burns & Co
New York
$12.3K – – –
TRCT
30
Tower Research Capital (TRC)
New York
$11.1K +$6.12K +4,306 +85%
Simplex Trading
31
Simplex Trading
Illinois
$9K -$525 -369 -4%
KSWA
32
Kathleen S. Wright Associates
Pennsylvania
$8.33K – – –
Wells Fargo
33
Wells Fargo
California
$6.34K +$711 +500 +10%
BTI
34
Blue Trust Inc
Georgia
$5.36K – – –
CFD
35
Creative Financial Designs
Indiana
$3.57K – – –
Fidelity Investments
36
Fidelity Investments
Massachusetts
$3.31K +$2.75K +1,931 +228%
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
$1.35K -$139 -98 -8%
TC
38
Truvestments Capital
Florida
$1.32K – – –
Bessemer Group
39
Bessemer Group
New Jersey
$1K – – –
HFS
40
Hughes Financial Services
Virginia
$825 +$1.09K +764 New
JP Morgan Chase
41
JP Morgan Chase
New York
$737 – – –
Osaic Holdings
42
Osaic Holdings
Arizona
$595 -$7.14K -5,017 -91%
RA
43
Rise Advisors
New York
$387 +$462 +325 New
Northwestern Mutual Wealth Management
44
Northwestern Mutual Wealth Management
Wisconsin
$306 +$366 +257 New
SS
45
SBI Securities
Japan
$126 – – –
CIAM
46
Caitong International Asset Management
Hong Kong
$1 -$350 -246 -100%
National Bank of Canada
47
National Bank of Canada
Quebec, Canada
$1 – – –
Citadel Advisors
48
Citadel Advisors
Florida
– -$313K -220,215 Closed
Renaissance Technologies
49
Renaissance Technologies
New York
– -$163K -100,000 Closed
Two Sigma Investments
50
Two Sigma Investments
New York
– -$107K -65,732 Closed
1
2
3

PDSB Hedge Fund Activity: Q1 2025 in Review

48 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in PDS Biotechnology (PDSB) for Q1 2025, worth a combined $9.81M — up 41% from $6.94M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of PDSB and 9 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 11 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $6.29M. The largest seller was Susquehanna International Group, cutting an estimated $315K.

  • 48 institutional investors held PDS Biotechnology (PDSB) as of Q1 2025, down from 52 in Q4 2024.
  • Funds reported $9.81M of PDS Biotechnology stock for Q1 2025, up 41% quarter-over-quarter.
  • 9 funds opened new PDS Biotechnology positions in Q1 2025 and 12 closed out, a net change of -3 holders.
  • The largest PDS Biotechnology buyer in Q1 2025 was Armistice Capital, an estimated $6.29M added.
  • The largest PDS Biotechnology seller in Q1 2025 was Susquehanna International Group, an estimated $315K sold.

Based on aggregated 13F filings for Q1 2025.